AR040545A1 - Cefalosporinas - Google Patents

Cefalosporinas

Info

Publication number
AR040545A1
AR040545A1 AR20030102508A ARP030102508A AR040545A1 AR 040545 A1 AR040545 A1 AR 040545A1 AR 20030102508 A AR20030102508 A AR 20030102508A AR P030102508 A ARP030102508 A AR P030102508A AR 040545 A1 AR040545 A1 AR 040545A1
Authority
AR
Argentina
Prior art keywords
carbon atoms
alkyl
carbonyl
hydrogen
formula
Prior art date
Application number
AR20030102508A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216418A external-priority patent/GB0216418D0/en
Priority claimed from GB0222177A external-priority patent/GB0222177D0/en
Priority claimed from GB0223977A external-priority patent/GB0223977D0/en
Priority claimed from GB0223974A external-priority patent/GB0223974D0/en
Priority claimed from GB0223976A external-priority patent/GB0223976D0/en
Priority claimed from GB0223975A external-priority patent/GB0223975D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of AR040545A1 publication Critical patent/AR040545A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Un compuesto de la fórmula (1): o de la fórmula (2). Reivindicación 1: Un compuesto de la fórmula (1): o de la fórmula (2): en donde: W es CH ó N, R1 es hidroxilo, alcoxilo (de 1 a 6 átomos de carbono), haloalcoxilo (de 1 a 6 átomos de carbono), hidroxicarbonilalcoxilo (de 1 a 6 átomos de carbono), o alcoxilo (de 1 a 6 átomos de carbono)-carbonilalcoxilo (de 1 a 6 átomos de carbono), R2 es hidrógeno o una fracción de éster, R3 es hidrógeno, alquilo (de 1 a 6 átomos de carbono), alquenilo (de 2 a 6 átomos de carbono), o cicloalquilo (de 3 a 8 átomos de carbono), R4 es hidrógeno o alquilo (de 1 a 6 átomos de carbono), en las fórmulas (1) y (2) la parte cíclica A es ciclohexilo o fenilo, R5 y R6, independientemente uno del otro, son hidrógeno; alquilo (de 1 a 6 átomos de carbono); alquenilo (de 2 a 6 átomos de carbono); arilcarbonilo (de 6 a 18 átomos de carbono); alquilo (de 1 a 6 átomos de carbono)-carbonilo; ariloxilo (de 6 a 18 átomos de carbono)-alquilo (de 1 a 4 átomos de carbono)-carbonilo; alquilo (de 1 a 6 átomos de carbono)-carbonilarilo (de 6 a 18 átomos de carbono)-carbonilo; heterociclilalquilo (de 1 a 6 átomos de carbono)-carbonilo, en donde heterociclilo comprende 5 ó 6 miembros del anillo y de 1 a 4 heteroátomos seleccionados a partir de N, O, ó S; alquilo (de 1 a 6 átomos de carbono)-sulfonilo, o arilo (de 6 a 18 átomos de carbono)-sulfonilo, X es NH, O, S, ó N-R8, en donde R8 es alquilo (de 1 a 6 átomos de carbono), o cicloalquilo (de 3 a 8 átomos de carbono), Y es O ó S, y n y m, independientemente uno del otro, son 0 ó 1.
AR20030102508A 2002-07-15 2003-07-11 Cefalosporinas AR040545A1 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0216418A GB0216418D0 (en) 2002-07-15 2002-07-15 Organic compound
GB0222177A GB0222177D0 (en) 2002-09-24 2002-09-24 Organic compounds
GB0223977A GB0223977D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223974A GB0223974D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223976A GB0223976D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223975A GB0223975D0 (en) 2002-10-15 2002-10-15 Organic compounds

Publications (1)

Publication Number Publication Date
AR040545A1 true AR040545A1 (es) 2005-04-13

Family

ID=30119477

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030102508A AR040545A1 (es) 2002-07-15 2003-07-11 Cefalosporinas

Country Status (23)

Country Link
US (1) US7485632B2 (es)
EP (1) EP1529050B1 (es)
JP (1) JP2005536499A (es)
KR (1) KR20050037553A (es)
CN (1) CN1678616A (es)
AR (1) AR040545A1 (es)
AT (1) ATE327239T1 (es)
AU (1) AU2003250056A1 (es)
BR (1) BR0312698A (es)
CA (1) CA2492373A1 (es)
CO (1) CO5680481A2 (es)
DE (1) DE60305506T2 (es)
EC (1) ECSP055538A (es)
ES (1) ES2268429T3 (es)
HK (1) HK1077299A1 (es)
IL (1) IL166120A0 (es)
MX (1) MXPA05000664A (es)
NO (1) NO20050781L (es)
PE (1) PE20040657A1 (es)
PL (1) PL373104A1 (es)
SI (1) SI1529050T1 (es)
TW (1) TW200422044A (es)
WO (1) WO2004007505A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189171A (ja) * 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
US10100068B2 (en) * 2014-04-16 2018-10-16 Sika Technology Ag Amidine group—or guanidine group—containing silane

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5093989A (es) 1973-10-25 1975-07-26
HUP9801387A3 (en) 1995-05-11 2000-12-28 Sandoz Ag Antibacterial cephalosporins
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
US20050234233A1 (en) 2005-10-20
MXPA05000664A (es) 2005-04-25
AU2003250056A1 (en) 2004-02-02
IL166120A0 (en) 2006-01-15
DE60305506D1 (de) 2006-06-29
PL373104A1 (en) 2005-08-08
HK1077299A1 (en) 2006-02-10
EP1529050A1 (en) 2005-05-11
CN1678616A (zh) 2005-10-05
NO20050781L (no) 2005-02-14
BR0312698A (pt) 2005-05-03
CO5680481A2 (es) 2006-09-29
TW200422044A (en) 2004-11-01
PE20040657A1 (es) 2004-11-08
WO2004007505A1 (en) 2004-01-22
US7485632B2 (en) 2009-02-03
ES2268429T3 (es) 2007-03-16
SI1529050T1 (sl) 2006-10-31
ATE327239T1 (de) 2006-06-15
CA2492373A1 (en) 2004-01-22
JP2005536499A (ja) 2005-12-02
ECSP055538A (es) 2005-03-10
EP1529050B1 (en) 2006-05-24
KR20050037553A (ko) 2005-04-22
DE60305506T2 (de) 2007-04-19

Similar Documents

Publication Publication Date Title
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
NO20054425L (no) Heteroarylkarbamoylbenzenderivater
NO20053614L (no) Nye pyridazin-3(2H)-on-derivater
WO2005028445A3 (en) Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
HUP0105077A2 (hu) Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
MX2009010024A (es) Nuevo compuesto de adenina.
TW200615267A (en) New bicyclic antibiotics
ECSP045369A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
NO982913L (no) Kinolin- og kinazolinforbindelser nyttige i terapi
TW200716531A (en) Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia
MY148980A (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
EA201070782A1 (ru) Производные оксадиазола, активные в отношении сфингозин-1-фосфата(sip)
DE50209786D1 (de) 7-aminotriazolopyrimidine zur bekämpfung von schadpilzen
CY1107903T1 (el) Παραγωγα ακυλαμινοθειαζολης και η χρηση τους ως αναστολεις του βητα-αμυλοειδους
CO5540307A2 (es) Derivados de piperidina utiles como moduladores de la activi dad del receptor de quimoquina
ATE374777T1 (de) Analoga als antitumorale verbindungen
AR041027A1 (es) Derivados de 1,2,3-triazol con actividad antimicrobiana particularmente fungicida
PE20010931A1 (es) Oxazolidinonas que tienen la funcion de una sulfoximina
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
HUP0301387A2 (hu) Szintetikus módszerek aplidin és új tumorellenes származékok előállítására
DE60239170D1 (de) Bicyclische Verbindungen
ATE412005T1 (de) Zyklosporinanalog
MXPA03009586A (es) Ciclosporina modificada que puede ser usada como un pro-farmaco y uso de la misma.
HUP0201357A2 (hu) Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával

Legal Events

Date Code Title Description
FB Suspension of granting procedure